News About: Pharm. Industry
Daewoong faced troubles with drug wholesale business.
Daewoong recently raises a lot of troubles with drug wholesalers, taking a superior business position toward the wholesalers in the business by dealing them without any distribution memorandum.
Daewoong was suppose...
Abbott Korea reported 111,800 million won of sales in 2005.
Abbott Korea reported the 2005 business performance as 111,820 million won of sales, which was 4.6% up from the previous year, 11,351 million won of operating income (78.6% up), 11,048 million won of ordinary income, ...
Hanall to expand plant for annual 200 BW of production capacity.
Hanall pharmaceutical company said on March 3 that because of the sales increases in the overseas markets and more new product development, the company needed to construct additional plant at 400-1 Sangseo dong Daedeo...
Choongwae to enter impotence drug market.
Choongwae recently made a technical license agreement with Japanese Tanabe for the semi-exclusive development of Avanafil, a new anti-impotence drug, in Korea and some part of Asian countries under a joint clinical st...
Bayer Healthcare sold 180,700 million won in 2005.
Bayer Healthcare reported on March 6 that the sales of 2005 was 180,700 million won including 96,074 million won of prescription drugs, 12,371 million won of consumer products including OTC drugs, 36,666 million won o...
KPMA vice chairman stressed to minimize Korea/America FTA impact"The issue on the Korea and U. S. free trade agreement raised a hectic impact to the pharmaceutical industry in terms of the influx of many generic drugs and the drug pricing ch...
|
Pacific and S&N in co-marketing for wound dressing business.Pacific Pharm. Co. signed a strategic business alliance with Smith & Nephew on Feb. 24 for the wound dressing products.
S&N appointed Pacific Pharm. for major business activi...
|
Unpredictable ranks among foreign multinational drug corporations
Nobody easily predicts which foreign drug company will rank the top amid a confused feature of their business progress as shown by GSK and Sanofi-Synthelabo a sharp rise whereas by Pfizer Korea a slow own.
The top ...
Vita500 promotional campaign to effect whopping sales growth.
Kwangdong has achieved a remarkable sales progress of Vita 500 drink recently after putting a new marketing promotional campaign focused on "No preservatives nor caffeine"
Starting from March Kwangdong will launch...
SBS to show Otzuka Korea as best company for returned goods.SBA, a Korean TV broadcasting station, staged a story of Otzuka Korea for the process of the drug disposals on a TV program.
Earlier the National Assembly Health and Welfare...
|
